NAB2 adenovirus

The NAB2 (NGFI-A binding protein 2) gene encodes a transcriptional repressor that plays a key role in regulating cell growth and differentiation. NAB2 is located on human chromosome 12 and regulates its activity by binding to the early growth response (EGR) family of transcription factors, particularly EGR1. This interaction is crucial for controlling processes such as cell proliferation, apoptosis, and wound healing. Dysregulation of NAB2 is associated with multiple pathological conditions, including cancer and fibrosis. Notably, chromosomal rearrangements involving NAB2 and STAT6 are frequently observed in solitary fibrous tumors (SFTs), resulting in the formation of NAB2-STAT6 fusion proteins that drive oncogenic signaling.

The NAB2 adenovirus is a recombinant adenoviral vector used to deliver or manipulate the NAB2 gene for research or therapeutic purposes. Adenoviruses are widely used in gene therapy due to their high transduction efficiency, ability to infect both dividing and non-dividing cells, and relatively large cargo capacity. The NAB2 adenovirus can be used to overexpress NAB2 to study its inhibitory effects on EGR-mediated transcription. Such vectors are valuable tools for exploring the role of NAB2 in cancer biology, fibrosis, and other diseases associated with aberrant EGR signaling. Furthermore, NAB2 adenoviruses may have therapeutic potential, particularly in cancers driven by NAB2-STAT6 fusions, where targeted gene editing or silencing could inhibit tumor growth.